
Opinion|Videos|July 5, 2024
Common Adverse Reactions to EGFR Therapy
Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.
Advertisement
Episodes in this series

- Provide a broad overview of common adverse effects associated with EGFR-targeted therapies in metastatic NSCLC.
- What proactive strategies do you recommend for preventing dermatologic toxicities, such as rash and acneiform eruptions, in patients receiving EGFR-targeted therapies?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Two-Drug HIV Regimens, Archived M184V Resistance, and Long-Acting Preference
2
Long-Acting HIV Injectables in Viremia and New Tenofovir-Free Oral Options
3
SNO 2026 Roundup: What Longer Follow-Up Means for Targeted Glioma Care
4
Overton FDA Nomination Withdrawn: What It Means for Pharmacists
5


